UMGi014-C

Registration Summary:

A P E C

The cell line is not submitted yet.

(only basic data is shown)

General

Cell Line
hPSCreg Name	UMGi014-C
Cell line type	Human induced pluripotent stem cell (hiPSC)
Last update	22nd May 2019
User feedback	Written by on No feedback available yet. Login to share your feedback, experiences or results with the research community.
Provider
Generator	University Medical Center Goettingen (UMG)
External Databases
Cellosaurus	CVCL_A4ZE
Wikidata	Q107117263
General Information
Publications	Li Wener et al. Effects of Hydroxychloroquine and Azithromycin on iPSC-derived Cardiomyocytes: Considerations for the Treatment of COVID-19 Patients. . 2021-08-19. Jakobi T et al. Transcriptional Effects of Candidate COVID-19 Treatments on Cardiac Myocytes. Frontiers in cardiovascular medicine. 2022;9:844441. Rapedius M et al. There is no F in APC: Using physiological fluoride-free solutions for high throughput automated patch clamp experiments. Frontiers in molecular neuroscience. 2022;15:982316. Li W et al. Synergistic Adverse Effects of Azithromycin and Hydroxychloroquine on Human Cardiomyocytes at a Clinically Relevant Treatment Duration. Pharmaceuticals (Basel, Switzerland). 2022 Feb 12;15(2). Seibertz F et al. A modern automated patch-clamp approach for high throughput electrophysiology recordings in native cardiomyocytes. Communications biology. 2022 Sep 15;5(1):969.
Subclones	UMGi014-C-1 UMGi014-C-2 UMGi014-C-3 UMGi014-C-4 UMGi014-C-5 UMGi014-C-6 UMGi014-C-7 UMGi014-C-8 UMGi014-C-9 UMGi014-C-10 UMGi014-C-11 UMGi014-C-12 UMGi014-C-13 UMGi014-C-14 UMGi014-C-15 UMGi014-C-16 UMGi014-C-17 UMGi014-C-18 UMGi014-C-19 UMGi014-C-20 UMGi014-C-21 UMGi014-C-22 UMGi014-C-23 UMGi014-C-24 UMGi014-C-25 UMGi014-C-26 UMGi014-C-27 UMGi014-C-28 UMGi014-C-29 UMGi014-C-30 UMGi014-C-31 UMGi014-C-32 UMGi014-C-33 UMGi014-C-34 UMGi014-C-35 UMGi014-C-36 UMGi014-C-37 UMGi014-C-38 UMGi014-C-39 UMGi014-C-40 UMGi014-C-41

hIPSC Derivation

General